{"disease":{"id":"immune-complex-diseases","name":"immune complex diseases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04446000","title":"Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CSL730 in Healthy Adult Subjects","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":52,"lead_sponsor_name":"CSL Behring","has_results":false},{"nct_id":"NCT03277703","title":"Flu Vaccine Response in Patients on Biologic Therapies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Stony Brook University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}